IRIS
VETRANO, ERICA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 2.602
AS - Asia 1.247
NA - Nord America 1.077
SA - Sud America 160
Continente sconosciuto - Info sul continente non disponibili 67
AF - Africa 18
Totale 5.171
Salva come PNG Salva come JPEG
Nazione #
RU - Federazione Russa 2.075
US - Stati Uniti d'America 1.046
SG - Singapore 380
CN - Cina 262
VN - Vietnam 226
IT - Italia 199
HK - Hong Kong 183
IE - Irlanda 132
BR - Brasile 127
KR - Corea 70
IN - India 52
DE - Germania 51
GB - Regno Unito 38
FR - Francia 24
JP - Giappone 18
MX - Messico 15
NL - Olanda 11
PL - Polonia 10
AR - Argentina 8
AT - Austria 8
CA - Canada 8
FI - Finlandia 8
BD - Bangladesh 7
SE - Svezia 7
TR - Turchia 7
CO - Colombia 6
EG - Egitto 6
ID - Indonesia 6
PK - Pakistan 6
LT - Lituania 5
PE - Perù 5
UA - Ucraina 5
VE - Venezuela 5
ZA - Sudafrica 5
AE - Emirati Arabi Uniti 4
AZ - Azerbaigian 4
CH - Svizzera 4
PT - Portogallo 4
BO - Bolivia 3
CR - Costa Rica 3
DK - Danimarca 3
EC - Ecuador 3
GR - Grecia 3
SA - Arabia Saudita 3
BE - Belgio 2
CZ - Repubblica Ceca 2
ES - Italia 2
ET - Etiopia 2
IL - Israele 2
IR - Iran 2
KG - Kirghizistan 2
MA - Marocco 2
MO - Macao, regione amministrativa speciale della Cina 2
PY - Paraguay 2
RS - Serbia 2
AL - Albania 1
BA - Bosnia-Erzegovina 1
BB - Barbados 1
BG - Bulgaria 1
EE - Estonia 1
GE - Georgia 1
HN - Honduras 1
HR - Croazia 1
IQ - Iraq 1
JM - Giamaica 1
KW - Kuwait 1
LA - Repubblica Popolare Democratica del Laos 1
LV - Lettonia 1
MU - Mauritius 1
MY - Malesia 1
NP - Nepal 1
PH - Filippine 1
PR - Porto Rico 1
RO - Romania 1
SN - Senegal 1
SY - Repubblica araba siriana 1
TJ - Tagikistan 1
TN - Tunisia 1
TT - Trinidad e Tobago 1
TW - Taiwan 1
UY - Uruguay 1
UZ - Uzbekistan 1
Totale 5.104
Salva come PNG Salva come JPEG
Città #
Moscow 747
San Jose 221
Singapore 196
Hong Kong 176
Dublin 126
Santa Clara 110
Chandler 81
Ashburn 79
Ho Chi Minh City 75
Hefei 70
Seoul 70
The Dalles 62
Naples 52
Hanoi 50
New York 44
Bengaluru 30
Los Angeles 30
Dallas 29
Beijing 26
Da Nang 18
Munich 18
Council Bluffs 13
São Paulo 13
Orem 12
Cambridge 11
Princeton 11
Roxbury 11
Caserta 10
Falkenstein 10
Atlanta 8
Haiphong 8
Memphis 8
Salerno 8
Chennai 7
Hải Dương 7
Liveri 7
Milan 7
Bremen 6
Hillsboro 6
Mexico City 6
Stockholm 6
Tokyo 6
Warsaw 6
Amsterdam 5
Can Tho 5
Chicago 5
Denver 5
Des Moines 5
Florence 5
Frankfurt am Main 5
Lahore 5
Seattle 5
Vienna 5
Baku 4
Belo Horizonte 4
Biên Hòa 4
Brasília 4
Brooklyn 4
Damietta 4
Helsinki 4
Houston 4
Istanbul 4
Johannesburg 4
Lisbon 4
Manchester 4
Paris 4
Rome 4
Yên Bái 4
Zurich 4
Andover 3
Bexley 3
Boydton 3
Chengdu 3
Dhaka 3
Guarulhos 3
Guayaquil 3
Ha Long 3
Honolulu 3
La Paz 3
Lappeenranta 3
Lima 3
Manaus 3
Mumbai 3
Nha Trang 3
Norwalk 3
Nuremberg 3
Phoenix 3
Rio de Janeiro 3
San Francisco 3
San José 3
Shenzhen 3
Terzigno 3
Toronto 3
Addis Ababa 2
An Giang Province 2
Andria 2
Asunción 2
Athens 2
Avellino 2
Banda Aceh 2
Totale 2.697
Salva come PNG Salva come JPEG
Nome #
Cardiac Hypertrophy: from Pathophysiological Mechanisms to Heart Failure Development 197
Association between Renal Function at Admission and COVID-19 in-Hospital Mortality in Southern Italy: Findings from the Prospective Multicenter Italian COVOCA Study 185
Effects of a Combination of Empagliflozin Plus Metformin vs. Metformin Monotherapy on NAFLD Progression in Type 2 Diabetes: The IMAGIN Pilot Study 160
ULTRASOUND TIPS IN THE LUNG CANCER DIAGNOSIS: A PILOT STUDY 160
Dysregulated Epicardial Adipose Tissue as a Risk Factor and Potential Therapeutic Target of Heart Failure with Preserved Ejection Fraction in Diabetes 155
Current Knowledge on the Pathophysiology of Lean/Normal-Weight Type 2 Diabetes 152
Peripheral Neuropathy in Diabetes Mellitus: Pathogenetic Mechanisms and Diagnostic Options 152
Coronary Microvascular Dysfunction in Diabetes Mellitus: Pathogenetic Mechanisms and Potential Therapeutic Options 151
Can Metformin Exert as an Active Drug on Endothelial Dysfunction in Diabetic Subjects? 146
Lack of effect on in-hospital mortality of drugs used during COVID-19 pandemic: Findings of the retrospective multicenter COVOCA study 140
Impact of Acute Kidney Injury on the COVID-19 In-Hospital Mortality in Octogenarian Patients: Insights from the COVOCA Study 135
HCC and molecular targeting therapies: Back to the future 135
Cardiovascular benefits from gliflozins: Effects on endothelial function 134
CURRENT HEPATOCELLULAR CARCINOMA SYSTEMIC PHARMACOLOGICAL TREATMENT OPTIONS 133
Impact of gliflozins on cardiac remodeling in patients with type 2 diabetes mellitus & reduced ejection fraction heart failure: A pilot prospective study. GLISCAR study 131
Impact of liver fibrosis on COVID-19 in-hospital mortality in Southern Italy 131
Pathophysiology, Functional Assessment and Prognostic Implications of Nutritional Disorders in Systemic Amyloidosis 127
EFFICACY OF COVID-19 VACCINATION IN PATIENTS WITH IMMUNE SYSTEM DISORDERS AND CANCER 125
Sex-difference of multifactorial intervention on cardiovascular and mortality risk in DKD: post-hoc analysis of a randomised clinical trial 125
Advances in the Insulin-Heart Axis: Current Therapies and Future Directions 125
Changes in clinical scenarios, management, and perspectives of patients with chronic hepatitis C after viral clearance by direct-acting antivirals 125
Pathophysiological mechanisms and clinical evidence of relationship between Nonalcoholic fatty liver disease (NAFLD) and cardiovascular disease 124
Effects of Metformin in Heart Failure: From Pathophysiological Rationale to Clinical Evidence 120
Oxidative Stress in Type 2 Diabetes: Impacts from Pathogenesis to Lifestyle Modifications 120
Non-alcoholic Fatty Liver Disease (NAFLD), Type 2 Diabetes, and Non-viral Hepatocarcinoma: Pathophysiological Mechanisms and New Therapeutic Strategies 117
Changes in clinical scenarios, management, and perspectives of patients with chronic hepatitis C after viral clearance by direct-acting antivirals 116
Effects of metformin in heart failure: From pathophysiological rationale to clinical evidence 115
Cardiovascular Benefits from Gliflozins: Effects on Endothelial Function 112
Modern Challenges in Type 2 Diabetes: Balancing New Medications with Multifactorial Care 111
Editorial - Direct-acting antivirals therapy in HCV patients with HCC: lights and shadow 110
Late Hepatocellular Carcinoma Occurrence in Patients Achieving Sustained Virological Response After Direct-Acting Antiviral Therapy: A Matter of Follow-Up or Something Else? 105
Oxidative Stress and Cardiovascular Complications in Type 2 Diabetes: From Pathophysiology to Lifestyle Modifications 100
Insulin–Heart Axis: Bridging Physiology to Insulin Resistance 93
null 93
The Diabetic Cardiomyopathy: The Contributing Pathophysiological Mechanisms 89
The Diabetic Cardiomyopathy: The Contributing Pathophysiological Mechanisms 89
Sodium-Glucose Cotransporter 2 Inhibitors in Patients with Diabetes and Coronary Artery Disease: Translating the Benefits of the Molecular Mechanisms of Gliflozins into Clinical Practice 87
Impact of Gliflozins on Right Heart Remodeling in Italian Patients with Type 2 Diabetes and Heart Failure: Results from the GLISCAR Real-World Study 85
Does a strict glycemic control during acute coronary syndrome play a cardioprotective effect? Pathophysiology and clinical evidence 83
Precision Medicine in Type 2 Diabetes Mellitus: Utility and Limitations 80
Impact of empagliflozin as add-on to metformin vs metformin continuation on MASLD progression in type 2 diabetes: The IMAGIN Study 74
The Dual Burden: Exploring Cardiovascular Complications in Chronic Kidney Disease 71
Impact of SGLT2 Inhibitors on Heart Failure: From Pathophysiology to Clinical Effects 53
Totale 5.171
Salva come PNG Salva come JPEG
Categoria #
all - tutte 17.550
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 17.550
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/202293 0 0 0 17 20 6 4 2 3 2 11 28
2022/2023292 17 15 8 17 35 16 4 22 133 8 5 12
2023/2024234 31 11 6 18 47 36 4 9 5 15 22 30
2024/2025712 6 13 3 11 103 76 102 68 133 65 59 73
2025/20263.765 193 234 199 118 324 1.909 295 190 125 77 57 44
2026/202760 28 32 0 0 0 0 0 0 0 0 0 0
Totale 5.171